Literature DB >> 24179928

Recurrent phaeohyphomycosis: a case report.

Sn Shirbur1, Sr Telkar, Bv Goudar, Tony Mathew.   

Abstract

Phaeohyphomycoses are rare, opportunistic, fungal infections which are usually seen in immunocompromised individuals. We are reporting a case of a 40-year-old man with recurrent cutaneous phaeohyphomycosis, who did not have any clinical evidence of immunodeficiency, who presented with signs which resembled a malignancy of the skin.

Entities:  

Keywords:  Fungal infection; Phaeohyphomycoses

Year:  2013        PMID: 24179928      PMCID: PMC3809667          DOI: 10.7860/JCDR/2013/5115.3390

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Dematiaceous fungal pathogens: analysis of ribosomal DNA gene polymorphism by polymerase chain reaction-restriction fragment length polymorphism.

Authors:  R B Caligiorne; M A de Resende; E Dias-Neto; S C Oliveira; V Azevedo
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

Review 2.  Dematiaceous fungi.

Authors:  Sanjay G Revankar
Journal:  Mycoses       Date:  2007-03       Impact factor: 4.377

3.  Primary cutaneous phaeohyphomycosis.

Authors:  V K Somani; F Razvi; V K Sharma; V N Sita; V Sucharita
Journal:  Indian J Dermatol Venereol Leprol       Date:  1996 Nov-Dec       Impact factor: 2.545

Review 4.  Subcutaneous pheohyphomycosis in India--a case report and review.

Authors:  Nand Lal Sharma; Vikram Mahajan; Ramesh Chander Sharma; Ashok Sharma
Journal:  Int J Dermatol       Date:  2002-01       Impact factor: 2.736

Review 5.  Phaeohyphomycosis.

Authors:  M G Rinaldi
Journal:  Dermatol Clin       Date:  1996-01       Impact factor: 3.478

6.  Emerging agents of phaeohyphomycosis: pathogenic species of Bipolaris and Exserohilum.

Authors:  M R McGinnis; M G Rinaldi; R E Winn
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

7.  Mohs micrographic surgery for the eradication of phaeohyphomycosis of the hand.

Authors:  Melissa A Bogle; Michael S Rabkin; Aaron K Joseph
Journal:  Dermatol Surg       Date:  2004-02       Impact factor: 3.398

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.